Catalyst Wire Dossier Catalyst Wire Dossier

ARI103094

· GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ARI103094, covering 2017-07-11 to 2017-07-11. Get the full timeline:

Most recent: Clinical Trial Update: ARI103094-Follow-Up Study for REDUCE Study Subjects

See pricing